ENSC Ensysce Biosciences, Inc.
$0.49▼ -5.62%
Healthcare
Other
After hours
$0.49▼ -0.37%
Sep 11, 7:49 PM ET
Volume 559.7K
Avg Volume (10D) 722.5K
Key Metrics & Fundamentals
Market Cap
$9.47M
P/E Ratio
–
Div Yield
–%
52W Range
0.23 - 2.75
% vs 50 MA
37.04%
% vs 200 MA
-15.16%
RSI-14
63.7
MACD Histogram
+0.0100
Beta (1Y vs SPY)
1.17
Free Cash Flow
-$1.96M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.56M
COGS
–
Operating Exp
$2.58M
Operating Income
-$2.58M
EBIT
-$2.58M
Pretax Income
-$2.57M
Net Income
-$2.57M
EPS (Diluted)
-0.20
Price & Volume History
Loading chart…
Recent News
Ensysce Biosciences Announces Upcoming Conference and Industry Event Participation
ACCESS Newswire · Sep 2, 2026 12:30 PM
Ensysce Biosciences Completes Final Phase of PF614-MPAR-102 Clinical Study
ACCESS Newswire · Aug 31, 2026 12:30 PM
Ensysce Biosciences to Showcase "A New Era in Pain Therapeutics" at PAINWeek 2026 Symposium
ACCESS Newswire · Aug 20, 2026 12:00 PM
Ensysce Biosciences Insider Bought Shares Worth $444,169, According to a Recent SEC Filing
MT Newswires · Aug 18, 2026 10:11 AM
ENSC Sets Itself Up Nicely for Critical Stage
Zacks Small Cap Research · Aug 14, 2026 12:12 PM
Ensysce Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights
ACCESS Newswire · Aug 13, 2026 8:15 PM
Ensysce Biosciences Completes Cy Biopharma Acquisition and Secures Up to $77 Million Private Financing
InvestorsHub · Aug 6, 2026 2:50 PM
BC-Most Active Stocks
Associated Press · Aug 6, 2026 2:30 PM
Ensysce Biosciences Announces Acquisition of Cy Biopharma and up to $77 Million Private Financing
ACCESS Newswire · Aug 6, 2026 12:00 PM
ENSC Makes Bold Move that Bolsters Pipeline and Finances
Zacks Small Cap Research · Aug 6, 2026 11:25 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ENSC's money flow as a full page
Social Sentiment
Avg -0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.